Molecular
diagnostics is a rapidly advancing field in medical science that uses advanced
techniques to detect and analyze genetic and molecular abnormalities in
biological samples, such as blood, tissue, or saliva. These techniques involve
the detection and analysis of DNA, RNA, and proteins at the molecular level,
providing accurate and sensitive diagnostic information for a wide range of
diseases and conditions.
Molecular
diagnostics has revolutionized the way we diagnose and treat diseases, enabling
early detection and personalized medicine tailored to the individual patient's
genetic makeup. With its ability to identify disease-causing genetic mutations
and biomarkers, molecular diagnostics is increasingly being used to guide
treatment decisions, monitor treatment response, and predict disease outcomes.
The
use of molecular diagnostics is rapidly expanding, with applications ranging
from infectious disease testing, cancer diagnosis and monitoring, and genetic
testing for inherited disorders. As technology continues to advance, molecular
diagnostics will undoubtedly continue to play a crucial role in the diagnosis
and treatment of diseases, improving patient outcomes and advancing the field
of medicine.
Our
report titled Molecular Diagnostics – A Way Forward to Improved Patient Outcome
provides detailed insights into this evolving modality and highlights the
following points-
- Reliable
diagnosis for communicable infectious diseases like COVID-19, dengue, malaria,
tuberculosis, influenza, HIV and hepatitis provided by is molecular diagnostics
- Emerging
application areas of molecular diagnostics include genetics, hematopathology,
cardiovascular diseases, and neurological diseases
- PCR
segment dominated the infectious disease molecular diagnostics market &
accounted for ~90% revenue in 2020
- Global
diagnostics market is dominated by players like Roche and Abbott
- Besides
Covid-19 reagents, TB reagents had the highest share in the Indian molecular
diagnostics reagent market in 2021.
- The
number of testing labs has increased from 14 in February 2020 to 106 VRDLs in
March 2022. India currently has 3000+ molecular testing laboratories
- Local
players like Molbio, Mylab and TATA MD are striving to make their place in the
Indian molecular diagnostics market. Some startups have also raised investments
in recent years